{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:20Z","timestamp":1787026460039,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02353","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:55:36Z","timestamp":1570582536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Dendritic Cell Vaccination in Metastatic Melanoma Turns \u201cNon-T Cell Inflamed\u201d Into \u201cT-Cell Inflamed\u201d Tumors"],"prefix":"10.3389","volume":"10","author":[{"given":"Jenny","family":"Bulgarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Tazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Granato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ridolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Maiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"de Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pancisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Gentili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Piccinini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Carbonaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio Eugenio","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ancarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Framarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Guidoboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/CMR.0000000000000356","article-title":"Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience","volume":"27","author":"de Rosa","year":"2017","journal-title":"Melanoma Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"91438","DOI":"10.1172\/jci.insight.91438","article-title":"Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients","volume":"2","author":"Gross","year":"2017","journal-title":"JCI Insight"},{"key":"B6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20041378","article-title":"Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen","volume":"201","author":"Lurquin","year":"2005","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.4049\/jimmunol.180.5.3585","article-title":"Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells","volume":"180","author":"Carrasco","year":"2008","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ni.3159","article-title":"Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells","volume":"16","author":"Carretero","year":"2015","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/1078-0432.CCR-11-2479","article-title":"Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma","volume":"18","author":"Wilmott","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1136044","DOI":"10.1080\/2162402X.2015.1136044","article-title":"Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma","volume":"5","author":"Cooper","year":"2016","journal-title":"Oncoimmunology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/2159-8290.CD-15-1545","article-title":"Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade","volume":"6","author":"Chen","year":"2016","journal-title":"Cancer Discov"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1158\/1078-0432.CCR-16-0698","article-title":"Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in melanoma","volume":"23","author":"Vilain","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1479-5876-11-135","article-title":"Low-dose temozolomide before dendritic-cell vaccination reduces. (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients","volume":"11","author":"Ridolfi","year":"2013","journal-title":"J Transl Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1479-5876-12-209","article-title":"Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and\/or preleukapheresis IFN-alpha in patients with metastatic melanoma: a randomised \u201cproof-of-principle\u201d phase II study","volume":"12","author":"de Rosa","year":"2014","journal-title":"J Transl Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline","volume":"45","author":"Eisenhauer","year":"2009","journal-title":". Eur J Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.celrep.2017.03.037","article-title":"Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis","volume":"19","author":"Tsujikawa","year":"2017","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1109\/IEMBS.2011.6091522","article-title":"Mosaicing of optical microscope imagery based on visual information","volume":"2011","author":"Carozza","year":"2011","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"B22","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1109\/IEMBS.2011.6091522","article-title":"Mosaicing of optical microscope imagery based on visual information","author":"Carozza","year":"2011","journal-title":"2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society"},{"key":"B23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1145\/1141911.1141920","article-title":"Image deformation using moving least squares","volume":"25","author":"Schaefer","year":"2006","journal-title":"ACM Transact Grap"},{"key":"B24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1109\/CBMS.2001.941749","article-title":"Medical image processing, analysis and visualization in clinical research","volume-title":"Proceedings 14th IEEE Symposium on Computer-Based Medical Systems. CBMS 2001","author":"McAuliffe","year":"2001"},{"key":"B25","unstructured":"Quantification of histochemical staining by color deconvolution2919\n            RuifrokAC\n            JohnstonDA\n          11531144Anal Quant Cytol Histol232001"},{"key":"B26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.201004104","article-title":"Metadata matters: access to image data in the real world","volume":"189","author":"Linkert","year":"2010","journal-title":"J Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1158\/1078-0432.CCR-13-2690","article-title":"Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration","volume":"20","author":"Bartlett","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8378","DOI":"10.1158\/0008-5472.CAN-10-2028","article-title":"Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma","volume":"70","author":"Anichini","year":"2010","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1080\/21645515.2017.1303582","article-title":"Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme","volume":"13","author":"Sokratous","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic cell-based immunotherapy: state of the art and beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/cdd.2013.67","article-title":"Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer","volume":"21","author":"Bracci","year":"2014","journal-title":"Cell Death Differ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1158\/0008-5472.CAN-10-1326","article-title":"Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients","volume":"70","author":"Palermo","year":"2010","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3389\/fimmu.2018.02265","article-title":"Dendritic cell cancer therapy: vaccinating the right patient at the right time","volume":"9","author":"van Willigen","year":"2018","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e021701","DOI":"10.1136\/bmjopen-2018-021701","article-title":"Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial. (ACDC Adjuvant Trial)","volume":"8","author":"Ridolfi","year":"2018","journal-title":"BMJ Open"},{"key":"B36","doi-asserted-by":"publisher","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:55:39Z","timestamp":1570582539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2019.02353"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02353","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,9]]},"article-number":"2353"}}